Stay updated on Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa Clinical Trial
Sign up to get notified when there's something new on the Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa Clinical Trial page.

Latest updates to the Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 has been added to the page, and the previous operation-status notices (Revision: v3.4.1) have been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide funding/status notice and updated revision to v3.4.1 (removing v3.4.0). The change does not alter the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a new 'Show glossary' feature and updated the page revision to v3.4.0. Capitalization adjustments were made for the 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' labels, and older lowercase variants were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check64 days agoChange DetectedIntroduces a dedicated Locations section with California as the study site, replacing the previous California Locations header. The footer now omits the HHS Vulnerability Disclosure link and the revision banner updates to v3.3.3.SummaryDifference0.2%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 with no visible edits to the study page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa Clinical Trial page.